Further research on the live
smallpox (variola) virus is no longer necessary as vaccinations and anti-viral
drugs have already been established. Hammond and Ching (2011) believe that the
need to keep the live virus has not existed for years, and further research
should not be permitted. What is more, there are no living human beings infected
with the smallpox virus to further advance the research into treatment and vaccination
of smallpox. Moreover, there is little evidence to suggest that any other
country has undisclosed stocks of the smallpox virus to use against us as a
bioweapon, and reasons for keeping the stocks ‘’relate to the legacy of the
cold war rivalries and undocumented and unproven fears (with no evidence) that
secret stocks of smallpox virus are held by; ‘’rogue states’’ or terrorists’’
(Hammond and Ching, 2011, p. 10). Ultimately, there is no hard evidence to
suggest that retaining the remaining stocks of smallpox would be beneficial for
further research into vaccinations and anti-viral drugs, nor is there any hard
evidence to suggest that any other country is holding stocks to use against us
as a bioweapon. Overall, the reasons given to keep the last remaining stocks of
the virus are weak and unfounded.
Hammond, E. and Ching, L.
(2011) Smallpox virus stocks at the 64th WHA: Implementing the conclusions of the major review. Switzerland:
Third World Network.
No comments:
Post a Comment